IgGenix, Inc.

About IgGenix, Inc.

IgGenix is a clinical-stage antibody discovery and development company focused on solving allergies and other immunological diseases. Their mission is to empower people to live without the constant fear of life-threatening allergic reactions by developing innovative therapeutic solutions.

Products & Services

IGNX001:A first-in-class injectable, allergen-specific therapeutic antibody for peanut allergy, currently in Phase 1 clinical trials.

Allergy Program #2:An undisclosed allergy treatment program in development, at 50% progress toward Phase 1.

Atopic Dermatitis Program:A program targeting atopic dermatitis, in early development at 12% progress toward Phase 1.

SEQ SIFTER™ Platform:A single cell RNA-sequencing-based discovery platform that captures rare human B cells to develop high-affinity, allergen-specific IgG antibodies to block allergic cascades.

Specialties

Antibody Discovery and Development Molecular Immunology Allergy Therapeutics Food and Environmental Allergies Rare Cell-Based Technologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 40000000 MR: - FA: 40M FAN: 40000000	D: 2023-02-06 FD: 2023-02-06	5 investors

Series B Latest

2023-02-06

$40.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jessica Grossman

Chief Executive Officer

H

Henry Lowman

Chief Scientific Officer

D

Derek Croote

Chief Technical Officer

S

Stephen Quake

Scientific Co-Founder

K

Kari Nadeau

M.D., Ph.D., F.A.A.A.A.I.

S

Samir Kaul

Board Member

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

IgGenix, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised